186 related articles for article (PubMed ID: 28962634)
1. Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.
Reijula E; Pietilä AM; Halkoaho A; Selander T; Martikainen K; Kälviäinen R; Keränen T
Trials; 2017 Sep; 18(1):444. PubMed ID: 28962634
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling.
Reijula E; Halkoaho A; Pietilä AM; Selander T; Kälviäinen R; Keränen T
Epilepsy Behav; 2015 Jul; 48():29-34. PubMed ID: 26037846
[TBL] [Abstract][Full Text] [Related]
3. Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants.
Reijula E; Halkoaho A; Pietilä AM; Selander T; Martikainen K; Kälviäinen R; Keränen T
Seizure; 2018 Aug; 60():61-67. PubMed ID: 29908425
[TBL] [Abstract][Full Text] [Related]
4. What motivates Parkinson's disease patients to enter clinical trials?
Valadas A; Coelho M; Mestre T; Guedes LC; Finisterra M; Noronha A; Rosa MM; Sampaio C; Ferreira JJ
Parkinsonism Relat Disord; 2011 Nov; 17(9):667-71. PubMed ID: 21715213
[TBL] [Abstract][Full Text] [Related]
5. Survey on general knowledge on Parkinson's disease in patients with Parkinson's disease and current clinical practice for Parkinson's disease among general neurologists from Southwest China.
Li J; Chen D; Song W; Chen K; Cao B; Huang R; Yang R; Shang H
Clin Neurol Neurosurg; 2014 Mar; 118():16-20. PubMed ID: 24529223
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).
Fleisher JE; Dahodwala NA; Xie SX; Mayo M; Weintraub D; Chodosh J; Shea JA
J Parkinsons Dis; 2016 Apr; 6(2):383-92. PubMed ID: 27061070
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitudes and perceptions of Parkinson's disease: A cross-sectional survey of Asian patients.
Jitkritsadakul O; Boonrod N; Bhidayasiri R
J Neurol Sci; 2017 Mar; 374():69-74. PubMed ID: 28104234
[TBL] [Abstract][Full Text] [Related]
8. Why do patients participate in long-term cardiovascular trials?--a questionnaire-based study.
Dellborg H; Hultsberg-Olsson G; Dellborg M
Scand Cardiovasc J; 2016; 50(2):83-7. PubMed ID: 26686535
[TBL] [Abstract][Full Text] [Related]
9. Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate.
Lim Y; Lim JM; Jeong WJ; Lee KH; Keam B; Kim TY; Kim TM; Han SW; Oh DY; Kim DW; Kim TY; Heo DS; Bang YJ; Im SA
Cancer Res Treat; 2017 Oct; 49(4):1033-1043. PubMed ID: 28392549
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
Rabey JM; Bass H; Bonuccelli U; Brooks D; Klotz P; Korczyn AD; Kraus P; Martinez-Martin P; Morrish P; Van Sauten W; Van Hilten B
Clin Neuropharmacol; 1997 Aug; 20(4):322-37. PubMed ID: 9260730
[TBL] [Abstract][Full Text] [Related]
11. Prescription pattern and awareness of disease and treatment in patients of Parkinson's disease.
Tripathi RK; Kapse SV; Potey AV
Neurodegener Dis Manag; 2017 Oct; 7(5):299-306. PubMed ID: 29043907
[TBL] [Abstract][Full Text] [Related]
12. "I Want to Do It, But I Want to Make Sure That I Do It Right." Views of Patients with Parkinson's Disease Regarding Early Stem Cell Clinical Trial Participation.
de Melo-Martín I; Holtzman M; Hacker KS
AJOB Empir Bioeth; 2020; 11(3):160-171. PubMed ID: 32516056
[No Abstract] [Full Text] [Related]
13. Factors associated with willingness to participate in clinical trials: a nationwide survey study.
Chu SH; Kim EJ; Jeong SH; Park GL
BMC Public Health; 2015 Jan; 15():10. PubMed ID: 25595373
[TBL] [Abstract][Full Text] [Related]
14. Long term understanding of study information in research participants with Parkinson's disease.
Ravina B; Swearingen C; Elm J; Kamp C; Kieburtz K; Kim SY
Parkinsonism Relat Disord; 2010 Jan; 16(1):60-3. PubMed ID: 19501011
[TBL] [Abstract][Full Text] [Related]
15. Requirements for Parkinson's disease pharmacotherapy from the patients' perspective: a questionnaire-based survey.
Wüllner U; Fuchs G; Reketat N; Randerath O; Kassubek J
Curr Med Res Opin; 2012 Jul; 28(7):1239-46. PubMed ID: 22686959
[TBL] [Abstract][Full Text] [Related]
16. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
[TBL] [Abstract][Full Text] [Related]
17. Clinical investigation of medicinal products in the treatment of Parkinson's disease (CPMP note for guidance). European Agency for Evaluation of Medicinal Products.
Eur Neuropsychopharmacol; 1999 Sep; 9(5):443-9. PubMed ID: 10523052
[TBL] [Abstract][Full Text] [Related]
18. Perceptions and Attitudes of Cancer Patients and Caregivers Towards Enrollment in Clinical Trials in Lebanon.
Salem R; Matar C; Assi R; Alameddine R; Temraz S; Shamseddine A; Mukherji D
J Cancer Educ; 2019 Apr; 34(2):334-338. PubMed ID: 29196906
[TBL] [Abstract][Full Text] [Related]
19. Barriers to Cancer Clinical Trial Participation Among Saudi Nationals: A Cross-Sectional Study.
Almutairi KM; Alonazi WB; Alodhayani AA; Vinluan JM; Moussa M; Al-Ajlan AS; Alsaleh K; Alruwaimi D; Alotaibi NE
J Relig Health; 2017 Apr; 56(2):623-634. PubMed ID: 27631996
[TBL] [Abstract][Full Text] [Related]
20. Characteristics associated with willingness to participate in a randomized controlled behavioral clinical trial using home-based personal computers and a webcam.
Dodge HH; Katsumata Y; Zhu J; Mattek N; Bowman M; Gregor M; Wild K; Kaye JA
Trials; 2014 Dec; 15():508. PubMed ID: 25539637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
